Key statistics
As of last trade, Rocket Pharmaceuticals Inc (9IP1:BER) traded at 13.47, 11.69% above the 52 week low of 12.06 set on Nov 20, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 12.10 |
---|---|
High | 13.47 |
Low | 12.08 |
Bid | 13.40 |
Offer | 13.61 |
Previous close | 12.46 |
Average volume | 28.44 |
---|---|
Shares outstanding | 91.16m |
Free float | 87.12m |
P/E (TTM) | -- |
Market cap | 1.17bn USD |
EPS (TTM) | -2.75 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 17:43 GMT.
More ▼
Press releases
- Rocket Pharmaceuticals Announces New England Journal of Medicine Publication of Phase 1 RP-A501 Long-Term Data and Presents at Late-Breaking Scientific Sessions at 2024 American Heart Association Conference
- Rocket Pharmaceuticals to Present Updated Data from the Phase 1 Clinical Trial of RP-A501 for Danon Disease at the American Heart Association’s 2024 Late-Breaking Science Sessions
- Rocket Pharmaceuticals to Participate in the UBS Global Healthcare Conference
- Rocket Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent Progress
- Rocket Pharmaceuticals Announces Completion of Enrollment in Phase 2 Pivotal Trial of RP-A501 for the Treatment of Danon Disease
- Rocket Pharmaceuticals Announces Appointment of Mikael Dolsten, M.D., Ph.D., to Board of Directors
- Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences
More ▼